Watch NSPR. Know when insiders buy.
One email the day a filing lands. Free.
NSPR
InspireMD, Inc.
0.75
+0.00 +0.00%
USD · close Sep 23
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $34.9MP/E —DIV YIELD —FCF YIELD -121.78%REV TTM $10.8M +53.4%NET INCOME −$52.5MNET CASH $10.1M52W 0.65 – 2.50SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $1.8M | −0.4% | -43.7% | −$14.4M | −$14.3M | — | -0.17 | −$10.9M | $330K | −$11.2M | Aug 14 |
| Q1 2026 · Mar 31 | $3.4M | +122.2% | 20.2% | −$14M | −$13.7M | — | -0.16 | −$12.3M | $194K | −$12.5M | May 7 |
| Q4 2025 · Dec 31derived | $3.1M | +61.6% | 37.5% | −$12.1M | −$11.8M | — | -0.12 | −$9.3M | $398K | −$9.7M | Mar 18 |
| Q3 2025 · Sep 30 | $2.5M | +39.4% | 34.2% | −$13.1M | −$12.7M | — | -0.17 | −$8.6M | $329K | −$9M | Nov 10 |
| Q2 2025 · Jun 30 | $1.8M | +2.2% | 17.6% | −$13M | −$13.2M | — | -0.26 | −$8.3M | $576K | −$8.9M | Aug 14 |
| Q1 2025 · Mar 31 | $1.5M | +1.2% | 19.1% | −$11.5M | −$11.2M | — | 0.22 | −$8.8M | $359K | −$9.2M | May 7 |
| Q4 2024 · Dec 31derived | $1.9M | +10.7% | 24.1% | −$9.4M | −$9.2M | — | -0.18 | −$6.8M | $311K | −$7.1M | Mar 18 |
| Q3 2024 · Sep 30 | $1.8M | +16.3% | 22.9% | −$8.5M | −$7.9M | — | -0.16 | −$5.7M | $421K | −$6.1M | Nov 10 |
| Q2 2024 · Jun 30 | $1.7M | — | 19.0% | −$8.3M | −$7.9M | — | -0.22 | −$4.4M | $475K | −$4.8M | Aug 4 |
| Q1 2024 · Mar 31 | $1.5M | — | 19.3% | −$7.4M | −$7M | — | -0.21 | −$5.1M | $195K | −$5.3M | May 8 |
| Q4 2023 · Dec 31derived | $1.8M | — | 28.7% | −$5.8M | −$5.4M | — | -0.13 | −$4.2M | $215K | −$4.4M | Mar 12 |
| Q3 2023 · Sep 30 | $1.6M | — | 28.1% | −$5.6M | −$5.2M | — | -0.15 | −$4M | $96K | −$4.1M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $9M | 29.5% | −$49.6M | −$48.8M | -543.3% | -0.76 | −$35.1M | $1.7M | −$36.8M | — | — |
| FY2024 · to Dec 31 | $7M | 21.5% | −$33.5M | −$32M | -456.6% | -0.76 | −$21.9M | $1.4M | −$23.3M | — | — |
| FY2023 · to Dec 31 | $6.2M | 29.1% | −$21.1M | −$19.9M | -321.0% | -0.82 | −$16.4M | $381K | −$16.8M | — | — |
| FY2022 · to Dec 31 | $5.2M | 21.6% | −$18.7M | −$18.5M | -357.6% | -2.35 | −$15.5M | $473K | −$16M | — | — |
| FY2021 · to Dec 31 | $4.5M | 16.8% | −$14.7M | −$14.9M | -331.9% | -2.03 | −$13.2M | $344K | −$13.6M | — | — |
| FY2020 · to Dec 31 | $2.5M | 3.3% | −$10.4M | −$10.5M | -424.3% | -6.97 | −$9.1M | $88K | −$9.2M | — | — |
Every number comes from InspireMD, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.